An oral nonopioid analgesic is often sufficient for acute treatment of mild to moderate migraine pain without severe nausea or vomiting. A triptan is the drug of choice for treatment of moderate to severe migraine in most patients without vascular disease.1 Treatment of pain when it is still mild to moderate in intensity improves headache response and reduces the risk of recurrence.
ANALGESICS — Aspirin and acetaminophen, used alone, together, or combination with caffeine, and nonsteroidal...
- Comparison Table: Triptans for Migraine (online only)
- Comparison Table: Some Drugs for Migraine Prevention in Adults (online only)
- Epcoritamab (Epkinly) for Diffuse Large B-Cell Lymphoma (DLBCL) (online only)
- Sotorasib (Lumakras) for NSCLC (online only)
- In Brief: Brexucabtagene autoleucel (Tecartus) for Acute Lymphoblastic Leukemia (online only)
- Asciminib (Scemblix) for Chronic Myeloid Leukemia (online only)
- Live Fecal Microbiota Oral Capsules (Vowst) for Prevention of CDI Recurrence
- Eflapegrastim (Rolvedon) for Prevention of Chemotherapy-Induced Febrile Neutropenia
- Cariprazine (Vraylar) for Adjunctive Treatment of Depression
- COVID-19 Update: An EUA for Vilobelimab (Gohibic) for COVID-19
- COVID-19 Update: Metformin to Prevent Long Covid?
- Polatuzumab vedotin (Polivy) for Lymphoma (online only)
- Enfortumab Vedotin (Padcev) for Urothelial Cancer (online only)
- Omidubicel (Omisirge) for Neutrophil Recovery Following Myeloablative Conditioning Therapy (online only)
The CDC is recommending that persons at high risk of mpox (see Table 1) receive two doses of the Jynneos vaccine. The recommendation follows reports of a recent cluster of mpox cases in the US and warnings about the risk of a renewed outbreak during the spring and summer as people gather for festivals and other events. The CDC does not recommend routine immunization against mpox for the general population.
MPOX — Mpox (formerly called monkeypox) is …